UW Launches New Institute to Advance AI-Driven Drug Discovery and Development

The University of Washington has opened the Institute for Innovations in Drug Delivery and Disposition (I2D3), a new research institute housed in the UW School of Pharmacy. The institute is led by three UW faculty members and brings together experts in AI, drug discovery, pharmacology, data science, and biotechnology to accelerate the development promising new therapies.